# Avocado Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/avocado-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Avocado Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are rand
Last reviewed: 2026-06-03
Reviewed by: Migaku Evidence Review
# Avocado Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Avocado Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial | randomized trial | 2 | 2026-06-01 | 10.1016/j.jnha.2026.100847 |
| Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review | narrative review | 3 | 2026-04-04 | 10.3390/medicina62040696 |

## What The Sources Report

- Dietary patterns rich in antioxidants, unsaturated fats, and fiber have been associated with favorable effects on brain health and cognitive performance. [Lee Grace J. (2026); evidence level 2]
- Polyphenol-rich foods such as blueberries and cocoa have been shown to enhance cerebral blood flow and brain activation and are linked to improved cognitive performance and reduced cognitive decline in older adults. [Lee Grace J. (2026); evidence level 2]
- The most common one includes vascular risk factors, which are central to the pathogenesis of VaD but also contribute significantly to AD and other dementias. [González-Cidad Aitor (2026); evidence level 3]
- These modifiable risk factors include arterial hypertension -the major risk factor at the population level-as well as dyslipidemia and high body mass index (BMI), all of which can trigger inflammation and stenosis of cerebral blood vessels, leading to reduced blood flow and neural tissue damage. [González-Cidad Aitor (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For avocado cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Lee Grace J. (2026). Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial. DOI: 10.1016/j.jnha.2026.100847. PMCID: PMC13098412. PMID: 41999682. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13098412/
- González-Cidad Aitor (2026). Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer’s Disease and Vascular Dementia: A Review. DOI: 10.3390/medicina62040696. PMCID: PMC13117986. PMID: 42075568. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13117986/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.